Home » Topics » Regulatory

Regulatory
RSS

Subcutaneous IL-2 boosts CD4 cell counts in HIV-infected patients

March 26, 1997

Luvox cleared for OCD in children and adolescents

March 26, 1997

Antidepressant effects of NKH-477

March 26, 1997

CPMP approves lepirudin

March 24, 1997

New formulation of podofilox receives FDA approval

March 24, 1997

RPR seeks FDA approval for new indications for Lovenox

March 24, 1997

RPR files for U.S. approval of CFC-free asthma inhalater

March 21, 1997

FDA clears midazolam for use in children

March 21, 1997

Dermagraft-TC cleared for marketing

March 20, 1997

Tretinoin gel launched in the U.S.

March 19, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for February 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...